Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Nomura, Kyoichi"" wg kryterium: Autor


Tytuł :
The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis.
Autorzy :
Abe T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Matsuo H; The Japanese Society for Apheresis Guidelines Preparation Committee.; Former President, The Japanese Society for Apheresis.
Abe R; The Japanese Society for Apheresis Guidelines Preparation Committee.
Abe S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Asada H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ashida A; The Japanese Society for Apheresis Guidelines Preparation Committee.
Baba A; The Japanese Society for Apheresis Guidelines Preparation Committee.
Eguchi K; The Japanese Society for Apheresis Guidelines Working Group.
Eguchi Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Endo Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Fujimori Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Furuichi K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Furukawa Y; The Japanese Society for Apheresis Guidelines Working Group.
Furuya M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Furuya T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hanafusa N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hara W; The Japanese Society for Apheresis Guidelines Preparation Committee.
Harada-Shiba M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hasegawa M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hattori N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hattori M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hidaka S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hidaka T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hirayama C; The Japanese Society for Apheresis Guidelines Working Group.
Ikeda S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Imamura H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Inoue K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ishizuka K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ishizuka K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ito T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Iwamoto H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Izaki S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kagitani M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kaneko S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kaneko N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kanekura T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kitagawa K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kusaoi M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Lin Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Maeda T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Makino H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Makino S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Matsuda K; The Japanese Society for Apheresis Guidelines Working Group.
Matsugane T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Minematsu Y; The Japanese Society for Apheresis Guidelines Working Group.
Mineshima M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Miura K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Miyamoto K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Moriguchi T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Murata M; The Japanese Society for Apheresis Guidelines Working Group.
Naganuma M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Nakae H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Narukawa S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Nohara A; The Japanese Society for Apheresis Guidelines Preparation Committee.
Nomura K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ochi H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ohkubo A; The Japanese Society for Apheresis Guidelines Working Group.
Ohtake T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Okada K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Okado T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Okuyama Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Omokawa S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Oji S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sakai N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sakamoto Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sasaki S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sato M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Seishima M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Shiga H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Shimohata H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sugawara N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sugimoto K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Suzuki Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Suzuki M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Tajima T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Takikawa Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Tanaka S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Taniguchi K; The Japanese Society for Apheresis Guidelines Working Group.
Tsuchida S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Tsukamoto T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Tsushima K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ueda Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Wada T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yamada H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yamada H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yamaka T; The Japanese Society for Apheresis Guidelines Working Group.
Yamamoto K; The Japanese Society for Apheresis Guidelines Working Group.
Yokoyama Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yoshida N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yoshioka T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yamaji K; The Japanese Society for Apheresis Guidelines Preparation Committee.; President, The Japanese Society for Apheresis.
Pokaż więcej
Źródło :
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy [Ther Apher Dial] 2021 Dec; Vol. 25 (6), pp. 728-876.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Utility of phrenic nerve conduction studies for identification of patients with neuromuscular diseases requiring invasive mechanical ventilation.
Autorzy :
Narukawa S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Ishizuka K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Sugimoto K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Pokaż więcej
Źródło :
Muscle & nerve [Muscle Nerve] 2021 Oct 28. Date of Electronic Publication: 2021 Oct 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome.
Autorzy :
Yamagishi Y; Department of Neurology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Kuwahara M; Department of Neurology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Suzuki H; Department of Neurology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Sonoo M; Department of Neurology, Teikyo University School of Medicine, Itabashi-ku, Tokyo, Japan.
Kuwabara S; Department of Neurology, Chiba University Graduate School of Medicine, Chiba, Chiba, Japan.
Yokota T; Department of Neurology, Tokyo Medical and Dental University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Kawagoe, Saitama, Japan.
Chiba A; Department of Neurology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.
Kaji R; Department of Clinical Neuroscience, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Tokushima, Japan.
Kanda T; Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Kaida KI; Department of Neurology, Saitama Medical Center, Kawagoe, Saitama, Japan.
Mutoh T; Department of Neurology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Yamasaki R; Department of Neurology, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Takashima H; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
Matsui M; Department of Neurology, Kanazawa Medical University, Kahoku-gun, Ishikawa, Japan.
Nishiyama K; Department of Neurology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Sobue G; Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Kusunoki S; Department of Neurology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan .
Pokaż więcej
Źródło :
Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2020 Dec; Vol. 91 (12), pp. 1339-1342. Date of Electronic Publication: 2020 Oct 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Mobility Limitation*
Gangliosides/*immunology
Guillain-Barre Syndrome/*immunology
Immunoglobulin G/*immunology
Age Factors ; Autoantibodies ; Diarrhea ; Electrodiagnosis ; G(M1) Ganglioside/immunology ; Guillain-Barre Syndrome/physiopathology ; Guillain-Barre Syndrome/therapy ; Humans ; Prognosis ; Respiration, Artificial ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany.
Autorzy :
Liu J; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Mori M; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Zimmermann H; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Brandt A; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Neurology, University of California, Irvine, California, USA.
Havla J; Institute of Clinical Neuroimmunology, LMU-Hospital, Ludwig-Maximilians Universiät München, Munich, Germany.
Tanaka S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Sugimoto K; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Uzawa A; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Asseyer S; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Cooper G; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Einstein Center for Neurosciences, Berlin, Germany.; Department of Experimental Neurology and Center for Stroke Research, Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Jarius S; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.
Bellmann-Strobl J; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Ruprecht K; Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Siebert N; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Masuda H; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Uchida T; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Ohtani R; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Meinl E; Institute of Clinical Neuroimmunology, LMU-Hospital, Ludwig-Maximilians Universiät München, Munich, Germany.
Kuempfel T; Institute of Clinical Neuroimmunology, LMU-Hospital, Ludwig-Maximilians Universiät München, Munich, Germany.
Paul F; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Einstein Center for Neurosciences, Berlin, Germany.; Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Kuwabara S; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan .
Pokaż więcej
Źródło :
Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2020 Nov 20. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
Autorzy :
Tanaka S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan. Electronic address: .
Hashimoto B; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Izaki S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Fukaura H; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2020 Jun; Vol. 41, pp. 102005. Date of Electronic Publication: 2020 Feb 12.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
B-Lymphocyte Subsets*
Demyelinating Autoimmune Diseases, CNS*/blood
Demyelinating Autoimmune Diseases, CNS*/cerebrospinal fluid
Demyelinating Autoimmune Diseases, CNS*/immunology
Demyelinating Autoimmune Diseases, CNS*/physiopathology
Optic Neuritis*/blood
Optic Neuritis*/cerebrospinal fluid
Optic Neuritis*/immunology
Optic Neuritis*/physiopathology
T-Lymphocyte Subsets*
Aquaporin 4/*immunology
Blood-Brain Barrier/*physiopathology
Myelin-Oligodendrocyte Glycoprotein/*immunology
Adult ; Female ; Humans ; Male ; Middle Aged ; Neuromyelitis Optica/blood ; Neuromyelitis Optica/cerebrospinal fluid ; Neuromyelitis Optica/immunology ; Neuromyelitis Optica/physiopathology
Czasopismo naukowe
Tytuł :
Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial.
Autorzy :
Tahara M; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan. Electronic address: .
Oeda T; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
Okada K; Department of Neurology, University of Occupational and Environmental Health, Kitakyushu, Japan.
Kiriyama T; Department of Neurology, Nara Medical University School of Medicine, Nara, Japan.
Ochi K; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Maruyama H; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Fukaura H; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
Nomura K; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
Shimizu Y; Department of Neurology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Mori M; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nakashima I; Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Misu T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Umemura A; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
Yamamoto K; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
Sawada H; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
Pokaż więcej
Źródło :
The Lancet. Neurology [Lancet Neurol] 2020 Apr; Vol. 19 (4), pp. 298-306. Date of Electronic Publication: 2020 Mar 18.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Aquaporin 4/*genetics
Immunologic Factors/*therapeutic use
Neuromyelitis Optica/*drug therapy
Rituximab/*therapeutic use
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Disability Evaluation ; Double-Blind Method ; Drug Therapy, Combination ; Evoked Potentials, Visual ; Female ; Humans ; Immunologic Factors/adverse effects ; Infusions, Intravenous ; Japan ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neuromyelitis Optica/diagnostic imaging ; Neuromyelitis Optica/genetics ; Prednisolone/therapeutic use ; Recurrence ; Rituximab/adverse effects ; Steroids/therapeutic use ; Treatment Outcome ; White Matter/diagnostic imaging ; Young Adult
Czasopismo naukowe
Tytuł :
[Anti-myelin oligodendrocyte glycoprotein antibody-positive neurologic disease, manifested as clinical course of classical Devic's disease: A case report].
Autorzy :
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University.
Yamaga T; Department of Neurology, Saitama Medical Center, Saitama Medical University.
Suzuki M; Department of Neurology, Saitama Medical Center, Saitama Medical University.
Tanaka S; Department of Neurology, Saitama Medical Center, Saitama Medical University.
Fukaura H; Department of Neurology, Saitama Medical Center, Saitama Medical University.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University.
Pokaż więcej
Źródło :
Rinsho shinkeigaku = Clinical neurology [Rinsho Shinkeigaku] 2020 Mar 31; Vol. 60 (3), pp. 219-222. Date of Electronic Publication: 2020 Feb 26.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Autoantibodies/*blood
Myelin-Oligodendrocyte Glycoprotein/*immunology
Neuromyelitis Optica/*diagnosis
Neuromyelitis Optica/*etiology
Adult ; Biomarkers/blood ; Humans ; Male ; Neuromyelitis Optica/diagnostic imaging ; Neuromyelitis Optica/immunology ; beta-Lactamases
Czasopismo naukowe
Tytuł :
Tacrolimus is effective for neuromyelitis optica spectrum disorders with or without anti-AQP4 antibody.
Autorzy :
Kojima M; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan. Electronic address: .
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Tanaka S; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Izaki S; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Hashimoto B; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Fukaura H; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2019 Dec 26; Vol. 39, pp. 101907. Date of Electronic Publication: 2019 Dec 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement.
Autorzy :
Sugimoto K; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of Neurology, Dongzhimen Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China.
Mori M; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan. Electronic address: .
Liu J; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Tanaka S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Kaneko K; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurology, National Hospital Organization Miyagi National Hospital, Miyagi, Japan.
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Takahashi T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurology, National Hospital Organization Yonezawa National Hospital, Yonezawa, Japan.
Uzawa A; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Uchida T; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Masuda H; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Ohtani R; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Hiwasa T; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kuwabara S; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Pokaż więcej
Źródło :
Journal of neuroimmunology [J Neuroimmunol] 2019 Nov 15; Vol. 336, pp. 577021. Date of Electronic Publication: 2019 Aug 21.
Typ publikacji :
Journal Article
MeSH Terms :
Judgment*
Autoantibodies/*blood
Flow Cytometry/*standards
Myelin-Oligodendrocyte Glycoprotein/*blood
Adult ; Female ; Flow Cytometry/methods ; HEK293 Cells ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/blood ; Multiple Sclerosis/diagnosis ; Neuromyelitis Optica/blood ; Neuromyelitis Optica/diagnosis ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Intravascular large B-cell lymphoma involving large blood vessels, three autopsy cases.
Autorzy :
Sato S; Department of Hematology, Shonan Kamakura General Hospital, Kamakura, Japan.; Department of Pathology, Tokai University, School of Medicine, Isehara, Japan.
Teshima S; Department of Pathology, Shonan Kamakura General Hospital, Kamakura, Japan.
Nakamura N; Department of Pathology, Tokai University, School of Medicine, Isehara, Japan.
Ohtake T; Department of Nephrology, Immunology, and Vascular Medicine, Shonan Kamakura General Hospital, Kamakura, Japan.
Kikuchi J; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Kishi H; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.; Department of Pathology, Doai Memorial Hospital, Tokyo, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Kurose N; Department of Pathology, Kanazawa Medical University, Kanazawa, Japan.
Masaki Y; Department of Hematology and Immunology, Kanazawa Medical University, Kanazawa, Japan.
Tamaru JI; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Pokaż więcej
Źródło :
Pathology international [Pathol Int] 2019 Feb; Vol. 69 (2), pp. 97-103. Date of Electronic Publication: 2019 Jan 23.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Lymphoma, Large B-Cell, Diffuse/*pathology
Vascular Neoplasms/*pathology
Aged ; Female ; Humans ; Male ; Middle Aged ; Neoplastic Cells, Circulating/pathology
Czasopismo naukowe
Tytuł :
CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.
Autorzy :
Kaneko K; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Sato DK; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.; Department of Neurology, Brain Institute and Hospital Sao Lucas Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.; Department of Neurology, São Paulo University, São Paulo, Brazil.
Nakashima I; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.; Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Ogawa R; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Akaishi T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.; Department of Neurology, Yonezawa National Hospital, Yonezawa, Japan.
Takai Y; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Nishiyama S; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Takahashi T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.; Department of Neurology, Yonezawa National Hospital, Yonezawa, Japan.
Misu T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Kuroda H; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tanaka S; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
Nomura K; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
Hashimoto Y; Department of Pediatrics, Chiba Kaihin Municipal Hospital, Chiba, Japan.
Callegaro D; Department of Neurology, São Paulo University, São Paulo, Brazil.
Steinman L; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Fujihara K; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.; Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Fukushima, Japan.; Multiple Sclerosis and Neuromyelitis Optica Center, Tohoku Research Institute for Neuroscience, Koriyama, Japan.
Aoki M; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Pokaż więcej
Źródło :
Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2018 Sep; Vol. 89 (9), pp. 927-936. Date of Electronic Publication: 2018 Jun 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Aquaporin 4/*cerebrospinal fluid
Cytokines/*cerebrospinal fluid
Immunoglobulin G/*cerebrospinal fluid
Multiple Sclerosis/*cerebrospinal fluid
Myelin-Oligodendrocyte Glycoprotein/*cerebrospinal fluid
Neuromyelitis Optica/*cerebrospinal fluid
Adolescent ; Adult ; Aged ; Case-Control Studies ; Child ; Child, Preschool ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/therapy ; Young Adult
Czasopismo naukowe
Tytuł :
Mean Platelet Volume Is Associated with Early Neurological Deterioration in Patients with Branch Atheromatous Disease: Involvement of Platelet Activation.
Autorzy :
Oji S; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan. Electronic address: .
Tomohisa D; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Hara W; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Tajima T; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Suzuki M; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Saito A; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Yoshida N; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Nomura K; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2018 Jun; Vol. 27 (6), pp. 1624-1631. Date of Electronic Publication: 2018 Feb 07.
Typ publikacji :
Journal Article
MeSH Terms :
Mean Platelet Volume*
Platelet Activation*
Brain Ischemia/*blood
Stroke/*blood
Adult ; Aged ; Aged, 80 and over ; Area Under Curve ; Brain Ischemia/diagnosis ; Brain Ischemia/physiopathology ; Brain Ischemia/therapy ; Disability Evaluation ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Prognosis ; ROC Curve ; Retrospective Studies ; Risk Factors ; Stroke/diagnosis ; Stroke/physiopathology ; Stroke/therapy ; Time Factors
Czasopismo naukowe
Tytuł :
Vertebral Artery Stump Syndrome.
Autorzy :
Suzuki M; Department of Neurology, Saitama Medical Center, Saitama Medical University, Japan.
Dembo T; Department of Neurology, Saitama Medical Center, Saitama Medical University, Japan.
Hara W; Department of Neurology, Saitama Medical Center, Saitama Medical University, Japan.
Tajima T; Department of Neurology, Saitama Medical Center, Saitama Medical University, Japan.
Yamashita M; Department of Laboratory Medicine, Saitama Medical Center, Saitama Medical University, Japan.
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2018 Mar 01; Vol. 57 (5), pp. 733-736. Date of Electronic Publication: 2017 Nov 20.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Cerebral Infarction/*etiology
Lateral Medullary Syndrome/*complications
Lateral Medullary Syndrome/*diagnostic imaging
Stroke/*etiology
Aged ; Cerebral Angiography ; Cerebral Infarction/diagnostic imaging ; Computed Tomography Angiography ; Diffusion Magnetic Resonance Imaging ; Humans ; Male ; Stroke/diagnostic imaging ; Ultrasonography ; Vertebral Artery/diagnostic imaging
SCR Disease Name :
PICA syndrome
Czasopismo naukowe
Tytuł :
Markers for Guillain-Barré syndrome with poor prognosis: a multi-center study.
Autorzy :
Yamagishi Y; Department of Neurology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Suzuki H; Department of Neurology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Sonoo M; Department of Neurology, Teikyo University School of Medicine, Tokyo, Japan.
Kuwabara S; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yokota T; Department of Neurology, Tokyo Medical and Dental University, Faculty of Medicine, Tokyo, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Faculty of Medicine, Kawagoe, Japan.
Chiba A; Department of Neurology, Kyorin University, Faculty of Medicine, Mitaka, Japan.
Kaji R; Department of Neurology, Tokushima University, Faculty of Medicine, Tokushima, Japan.
Kanda T; Department of Neurology, Yamaguchi University, Faculty of Medicine, Ube, Japan.
Kaida K; Department of Neurology, National Defense Medical College, Tokorozawa, Japan.
Ikeda SI; Department of Neurology, Shinshu University, Faculty of Medicine, Matsumoto, Japan.
Mutoh T; Department of Neurology, Fujita Health University School of Medicine, Faculty of Medicine, Toyoake, Japan.
Yamasaki R; Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takashima H; Department of Neurology, Kagoshima University, Faculty of Medicine, Kagoshima, Japan.
Matsui M; Department of Neurology, Kanazawa Medical University, Kahoku, Japan.
Nishiyama K; Department of Neurology, Kitazato University, Faculty of Medicine, Sagamihara, Japan.
Sobue G; Department of Neurology, Nagoya University, Graduate School of Medicine, Nagoya, Japan.
Kusunoki S; Department of Neurology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Pokaż więcej
Źródło :
Journal of the peripheral nervous system : JPNS [J Peripher Nerv Syst] 2017 Dec; Vol. 22 (4), pp. 433-439. Date of Electronic Publication: 2017 Sep 11.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Mobility Limitation*
Outcome Assessment, Health Care*
Respiration, Artificial*
Severity of Illness Index*
Guillain-Barre Syndrome/*diagnosis
Immunoglobulin G/*blood
Adult ; Female ; Follow-Up Studies ; Guillain-Barre Syndrome/blood ; Guillain-Barre Syndrome/physiopathology ; Guillain-Barre Syndrome/therapy ; Humans ; Japan ; Male ; Middle Aged ; Patient Admission ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
A clinical predictive score for postoperative myasthenic crisis.
Autorzy :
Kanai T; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
Uzawa A; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
Sato Y; Department of Global Clinical Research, Graduate School of Medicine, Chiba University, Chiba.
Suzuki S; Department of Neurology, Keio University School of Medicine, Tokyo.
Kawaguchi N; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
Himuro K; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
Oda F; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
Ozawa Y; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
Nakahara J; Department of Neurology, Keio University School of Medicine, Tokyo.
Suzuki N; Department of Neurology, Keio University School of Medicine, Tokyo.
Takahashi YK; Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo.
Ishibashi S; Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo.
Yokota T; Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo.
Ogawa T; Department of Neurology, Juntendo University School of Medicine, Tokyo.
Yokoyama K; Department of Neurology, Juntendo University School of Medicine, Tokyo.
Hattori N; Department of Neurology, Juntendo University School of Medicine, Tokyo.
Izaki S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama.
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama.
Kaneko J; Department of Neurology, Kitasato University School of Medicine, Kanagawa.
Nishiyama K; Department of Neurology, Kitasato University School of Medicine, Kanagawa.
Yoshino I; Department of General Thoracic Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Kuwabara S; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
Pokaż więcej
Źródło :
Annals of neurology [Ann Neurol] 2017 Nov; Vol. 82 (5), pp. 841-849. Date of Electronic Publication: 2017 Nov 10.
Typ publikacji :
Journal Article; Multicenter Study; Validation Study
MeSH Terms :
Myasthenia Gravis/*diagnosis
Postoperative Complications/*diagnosis
Female ; Humans ; Male ; Middle Aged ; Myasthenia Gravis/surgery ; Retrospective Studies ; Risk Factors ; Thymectomy/adverse effects
Czasopismo naukowe
Tytuł :
Immunoadsorption in neurological disorders.
Autorzy :
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan. Electronic address: .
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan. Electronic address: .
Pokaż więcej
Źródło :
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2017 Oct; Vol. 56 (5), pp. 671-676. Date of Electronic Publication: 2017 Aug 26.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immunosorbent Techniques*
Autoantibodies/*blood
Nervous System Diseases/*therapy
Humans ; Nervous System Diseases/immunology ; Plasma Exchange
Czasopismo naukowe
Tytuł :
Open Label Trial of the Efficacy and Safety Profile of Rikkunshito used for the Treatment of Gastrointestinal Symptoms in Patients with Parkinson's Disease: A Pilot Study.
Autorzy :
Yakabi K; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Yamaguchi N; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Ono S; Department of Gastroenterology, National Hospital Organization Disaster Medical Center, Tokyo, Japan.
Yoshida N; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Hosomi E; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Hayashi K; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Ochiai M; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Maezawa K; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Pokaż więcej
Źródło :
Current therapeutic research, clinical and experimental [Curr Ther Res Clin Exp] 2017 Jul 31; Vol. 87, pp. 1-8. Date of Electronic Publication: 2017 Jul 31 (Print Publication: 2017).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.
Autorzy :
Kaneko K; Departments of Neurology and Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Sato DK; Departments of Neurology and Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan Faculty of Medicine, Department of Neurology, University of São Paulo, São Paulo, Brazil.
Nakashima I; Departments of Neurology and Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Nishiyama S; Departments of Neurology and Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tanaka S; Department of Neurology, Saitama Medical Center, Kawagoe, Japan.
Marignier R; Lyon Neuroscience Research Center INSERM U 1028/CNRS 5292, Lyon, France.
Hyun JW; Research Institute and Hospital of National Cancer Center, Seoul, Republic of Korea.
Oliveira LM; Faculty of Medicine, Department of Neurology, University of São Paulo, São Paulo, Brazil.
Reindl M; Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Seifert-Held T; Department of Neurology, Medical University of Graz, Graz, Austria.
Sepulveda M; Service of Neurology, Hospital Clinic and Institute d'Investigación Biomèdica August Pi Sunyer, University of Barcelona, Barcelona, Spain.
Siritho S; Department of Neurology, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Waters PJ; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Kurosawa K; Departments of Neurology and Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Akaishi T; Departments of Neurology and Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Kuroda H; Departments of Neurology and Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Misu T; Faculty of Medicine, Department of Neurology, University of São Paulo, São Paulo, Brazil.
Prayoonwiwat N; Department of Neurology, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Berger T; Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Saiz A; Service of Neurology, Hospital Clinic and Institute d'Investigación Biomèdica August Pi Sunyer, University of Barcelona, Barcelona, Spain.
Kim HJ; Research Institute and Hospital of National Cancer Center, Seoul, Republic of Korea.
Nomura K; Department of Neurology, Saitama Medical Center, Kawagoe, Japan.
Callegaro D; Faculty of Medicine, Department of Neurology, University of São Paulo, São Paulo, Brazil.
Fujihara K; Departments of Neurology and Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Aoki M; Departments of Neurology and Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Pokaż więcej
Źródło :
Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2016 Nov; Vol. 87 (11), pp. 1257-1259. Date of Electronic Publication: 2016 Jan 22.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Aquaporin 4/*immunology
Autoantibodies/*immunology
Myelin Sheath/*pathology
Myelin-Oligodendrocyte Glycoprotein/*immunology
Neurodegenerative Diseases/*immunology
Aquaporin 4/blood ; Humans ; Multiple Sclerosis, Relapsing-Remitting/cerebrospinal fluid ; Multiple Sclerosis, Relapsing-Remitting/immunology ; Myelin-Oligodendrocyte Glycoprotein/blood ; Neurodegenerative Diseases/pathology ; Neurodegenerative Diseases/physiopathology
Raport
Tytuł :
Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.
Autorzy :
Yamasaki R; Department of Neurological Therapeutics, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Matsushita T; Department of Neurological Therapeutics, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Fukazawa T; Sapporo Neurology Clinic, Sapporo, Japan.
Yokoyama K; Department of Neurology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Fujihara K; Department of Multiple Sclerosis Therapeutics, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Ogino M; Department of Neurology, Kitasato University School of Medicine, Sagamihara, Japan.
Yokota T; Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo, Japan.
Miyamoto K; Department of Neurology, Kinki University School of Medicine, Osaka, Japan.
Niino M; Department of Clinical Research, NHO Hokkaido Medical Center, Sapporo, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Tomioka R; Department of Neurology, Saitama Medical University, Saitama, Japan.
Tanaka M; Multiple Sclerosis Center, NHO Utano National Hospital, Kyoto, Japan.
Kawachi I; Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
Ohashi T; Department of Neurology, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan.
Kaida K; Department of Neurology, National Defense Medical College, Tokorozawa, Japan.
Matsui M; Department of Neurology, Kanazawa Medical University, Kanazawa, Japan.
Nakatsuji Y; Department of Neurology, Osaka University, Osaka, Japan.
Ochi H; Department of Neurology, Graduate School of Medicine, Ehime University, Matsuyama, Japan.
Fukaura H; Department of Neurology, Iwate Medical University, Morioka, Japan.
Kanda T; Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Nagaishi A; Department of Neurology, NHO Nagasaki Kawatana Medical Center, Kawatana, Japan.
Togo K; Clinical Statistics, Pfizer Japan Inc., Tokyo, Japan.
Mizusawa H; Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo, Japan.
Murai H; Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kira J; Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan .
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2016 Sep; Vol. 22 (10), pp. 1337-48. Date of Electronic Publication: 2015 Nov 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Glucocorticoids/*administration & dosage
Methylprednisolone/*administration & dosage
Multiple Sclerosis/*drug therapy
Neuromyelitis Optica/*drug therapy
Administration, Intravenous ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
The 36(th) Annual Meeting of the Japanese Society for Apheresis.
Autorzy :
Nomura K; Department of Neurology, Saitama Medical Center, Saitama, Japan. .
Pokaż więcej
Źródło :
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy [Ther Apher Dial] 2016 Aug; Vol. 20 (4), pp. 337-8.
Typ publikacji :
Editorial
MeSH Terms :
Blood Component Removal*
Societies, Medical*
Humans ; Japan
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies